{"id":"W4409777208","doi":"10.1016/j.jaad.2025.04.038","title":"Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Sanofi Genzyme; Union Chimique Belge; Sanofi; UCB; Bright Research Group","keywords":"Medicine; Open label; Psoriasis; Dermatology; Plaque psoriasis; Extension (predicate logic); Clinical trial; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004120064,0.0005146224,0.00143992,0.0002150507,0.0003426235,0.001021267,0.0004610834,0.0008327164,0.002309619],"category_scores_gemma":[0.002463105,0.0003252916,0.001812564,0.0002731924,0.0004180018,0.0006585232,0.0004226525,0.002038783,0.0004529152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003850345,"about_ca_system_score_gemma":0.0008672415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003741079,"about_ca_topic_score_gemma":0.0006013316,"domain_scores_codex":[0.9989684,0.0005643468,0.0000662153,0.0001021859,0.000153928,0.0001449705],"domain_scores_gemma":[0.9982773,0.0004138993,0.0005070777,0.0001557736,0.0001507343,0.0004951291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.863311,0.01213644,0.02718668,0.001113979,0.00273005,0.0001537609,0.0002837043,0.0007352484,0.009086608,0.0001919014,0.00336141,0.07970921],"study_design_scores_gemma":[0.6133148,0.22642,0.146504,0.0002857401,0.003320769,0.0006185838,0.0001507987,0.001270039,0.002575397,0.0004728117,0.004996395,0.00007063747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918283,0.005189275,0.000214474,0.0002359235,0.00005260521,0.0004141143,0.0006131803,0.00002406729,0.001428061],"genre_scores_gemma":[0.9948475,0.001585198,0.0004887761,0.0004612968,0.0001431829,0.0004825731,0.00122373,0.000009737466,0.0007580477],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004120064,"threshold_uncertainty_score":0.02178925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02517035636229951,"score_gpt":0.2934647518648225,"score_spread":0.268294395502523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}